Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-12-12

FDA Approved: DEFLAZACORT — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved Amneal Pharmaceuticals NY LLC's original application for a generic version of deflazacort.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Deflazacort (generic) (Deflazacort)

Snippet

ORIG AP for DEFLAZACORT (DEFLAZACORT)